We invite you to read our new article published in PLOS One. Our objective was to examine the basic characteristics of seamless early-phase oncology trials registered on the ClinicalTrials.gov database and to determine their results reporting rates.

Come and see REMEDY’s new publication! Our aim was to describe the risks and benefits of basket clinical trials in oncology.

We are pleased to announce that Marcin Waligora together with Mohammad Hosseini have been appointed as co-editors of the ‘Research Ethics Forum’ series in Springer Nature. This book series aims to foster discussions about the ethics of research, covering foundational, normative, meta-ethical, and practical issues.

Tomasz Krawczyk participated in the EACME2024 Conference „Translating Ethics into Healthcare Practice and Research. Potentials and Risks” which took place in Halle/Saale on September 12-14th 2024. He presented a speech entitled “Meaningful inclusion? Influence of Research Institutions on Epistemic Injustice within Public and Patient Involvement”.

On September 10-13, Katarzyna Klas from our team attended the Global Evidence Summit 2024 in Prague. She presented the results of the study “Characteristics and Reporting of Seamless Early-Phase Trials in Oncology – A Cross-Sectional Analysis of Trials Registered on ClinicalTrials.gov”.